Skip to content
Subscriber Only

Carlyle Acquires 50% Stake in Medical-Device Maker Resonetics

  • The deal values GTCR-backed Resonetics at about $2.25 billion
  • Executive says he sees ‘M&A opportunity to grow this company’

Carlyle Group Inc. has acquired a 50% stake in medical-device manufacturer Resonetics in a deal that values the target company at about $2.25 billion.

“One of our big theses is providing outsourced services to different health-care end-markets, whether they’re hospitals, pharma companies or med-tech companies,” Bobby Schmidt, a Carlyle managing director, said in an interview. “We want to invest behind companies that provide services at a higher quality and lower cost than what your customers can do for themselves, and that’s exactly what Resonetics does.”